On the 24th of August 2001, a group of business and licensing executives united in Basel and founded the Swiss Pharma Licensing Group. The first Board defined objectives, recruited members and set up the foundation for today’s association.
It is a great pleasure to inform you about the collaboration between Swiss HLG and our international network IPLS (www.ipls.online) for the next spring conference “Rebound & Recover” planned for 21st-22nd April.
At this occasion, you’ll have the opportunity to set up virtual one-to-one business meetings with your peers, without traveling, over 2 days and participate to several conferences to keep you up-to-date about the trends in our industry. This will help you and your business during this pandemic to substitute your business travels.
Take advantage of the early bird rate and register asap at: www.ipls.online. If you need any help please contact Adam Collins at firstname.lastname@example.org or Andrew Dean at email@example.com
Several sponsoring opportunities are also offered, to give more visibility to your company and business inside this network of over 1’700 BD&L professionals. Join current sponsors:
Financing and Deal-making in turbulent times, 2nd March 2021, 3.00pm – 6.00pm CET
Adapting ongoing clinical trials
Adapting business plans and operations
Industrial association and government resources
Health authority guidelines
Swiss task forces and initiatives
Partnering & collaboration resources
Sales & marketing resources
Scientific materials and tools (reference samples etc)
Diagnostic, Therapeutic & Vaccine developments
Interesting Reads / Literature